HF
STLNW

HRT Financial’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

HRT Financial’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,098
Closed – – 3137
2024
Q2 		$0 Buy
+11,098
New +$856 ﹤0.01% 3112
2021
Q3 		– Sell
-11,921
Closed -$20K – 3761
2021
Q2 		$20K Sell
11,921
-1,600
-12% -$2.15K ﹤0.01% 2728
2021
Q1 		$16K Hold
13,521
– – ﹤0.01% 2606
2020
Q4 		$26K Hold
13,521
– – ﹤0.01% 1736
2020
Q3 		$22K Buy
+13,521
New +$22.2K ﹤0.01% 1770

Other funds holding STLNW

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

HRT Financial's STLNW Position: Q3 2024 in Review

HRT Financial sold out of Starling Oncology, Inc. Warrant (STLNW) in Q3 2024, closing a stake of 11,098 shares.

HRT Financial first reported a position in STLNW in Q3 2020 and held it in 5 quarters. The position peaked at $26K in Q4 2020. 15 funds tracked by Wall St. Rank hold STLNW as of Q3 2024.

  • HRT Financial reported no remaining Starling Oncology, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 11,098 Starling Oncology, Inc. Warrant shares in Q3 2024.
  • HRT Financial first reported a position in Starling Oncology, Inc. Warrant in Q3 2020 and held it in 5 quarters.
  • HRT Financial's Starling Oncology, Inc. Warrant position peaked at $26K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.